Research Site US-97202-001008 — Kansas City, Kansas

Research Site US-97202-001008 is a clinical research site located in Kansas City, Kansas, United States 66112.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Research Site US-97202-001008 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Obesity in Diabetes, Type 2 Diabetes Mellitus (T2DM).

Sponsors: Metsera, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Research Site US-97202-001008?

Research Site US-97202-001008 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Research Site US-97202-001008 conducted?

Research Site US-97202-001008 has 1 clinical trials on record, with 1 currently active. Their work covers Obesity in Diabetes, Type 2 Diabetes Mellitus (T2DM).

Is Research Site US-97202-001008 accredited by Crixeo Health?

Research Site US-97202-001008 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Research Site US-97202-001008?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.